The Government of India's Department of Biotechnology (DBT) and Bharat Biotech announced positive results from a Phase III clinical trial of a rotavirus vaccine developed and manufactured in India. Data from the trial, presented at the International Symposium on Rotavirus Vaccines for India -The Evidence and the Promise, showed ROTAVAC® to have an excellent safety and efficacy profile...
More...
More...